Thiosemicarbazones as anti-virals and immunopotentiators

The present invention is directed to novel immune potentiators, novel vaccine adjuvants, novel compounds and pharmaceutical compositions, novel methods for treating viral infections, including HCV, by administering the compounds, and novel methods for modulating an immune response by administering t...

Full description

Saved in:
Bibliographic Details
Main Authors NG SIMON, WEINER AMY J, BRAMMEIER NATHAN, BARSANTI PAUL A, DIEBES ANTHONY, WAGMAN ALLAN S, VALIANTE NICHOLAS, NI ZHI-JIE, WANG WEIBO, PFISTER KEITH B, LAGNITON LIANA MARIE, PHILBIN CASEY
Format Patent
LanguageEnglish
Published 21.04.2009
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to novel immune potentiators, novel vaccine adjuvants, novel compounds and pharmaceutical compositions, novel methods for treating viral infections, including HCV, by administering the compounds, and novel methods for modulating an immune response by administering the compounds.
Bibliography:Application Number: US20030748071